• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.79% Nasdaq Up0.16%

    More On JUBILANT.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Jubilant Life Sciences Limited (JUBILANT.NS)

    -NSE
    165.45 Down 3.95(2.33%) Jan 23, 4:59AM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2014Mar 31, 2013Mar 31, 2012Mar 31, 2011
    Total Revenue 58,034,000   51,660,000   43,031,000   34,456,000  
    Cost of Revenue32,558,000  27,768,000  22,606,000  18,741,000  
    Gross Profit 25,475,000   23,892,000   20,426,000   15,715,000  
    Operating Expenses
    Research Development -   -   -   -  
    Selling General and Administrative -   -   -   -  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses50,547,000  43,459,000  36,188,000  30,423,000  
    Operating Income or Loss 7,487,000   8,201,000   6,844,000   4,034,000  
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -   -  
    Earnings Before Interest And Taxes7,487,000  8,201,000  6,844,000  4,034,000  
    Interest Expense(3,064,000)(2,848,000)(2,215,000)(1,081,000)
    Income Before Tax -   -   -   -  
    Income Tax Expense696,000  1,524,000  684,000  134,000  
    Minority Interest(286,000)(361,000)(311,000)25,000  
    Net Income From Continuing Ops1,376,000  1,888,000  457,000  2,272,000  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 1,090,000   1,527,000   146,000   2,297,000  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares -   -   -   -  

    Currency in INR.